Drug Approval | October 20, 2021
FDA approves Cyltezo, the first interchangeable biosimilar to Humira
Second interchangeable biosimilar product approved by agency
Second interchangeable biosimilar product approved by agency
The panel concurred that these supplements resolved post-Covid-19 fatigue and muscle weakness
The division is expected to grow to over a 100-member strong team by 2022
The new products include the COAG Line automated, semi-automated and POC systems manufactured by Diagon Hungary
ICICI Direct gives an update on the 12 companies that it has covered in the healthcare universe. A report
The Amplitude Solution gives laboratories the ability to scale Covid-19 PCR testing and process up to 8,000 samples a day
Drugs and pharmaceuticals were among the top eight export items in H1FY22, according to a Care Ratings report.
It is the first presbyopia-correcting lens implant for cataract surgery
The first patient dosed with VX-880 demonstrated restoration of insulin production and achieved C-peptide of 560 pmol/L in response to Mixed Meal Tolerance Test (MMTT) at Day 90 visit
The WHO chief scientist Soumya Swaminathan tweeted on Oct. 17
Subscribe To Our Newsletter & Stay Updated
